Anna Roppelt

539 total citations
22 papers, 80 citations indexed

About

Anna Roppelt is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Anna Roppelt has authored 22 papers receiving a total of 80 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 6 papers in Hematology and 5 papers in Genetics. Recurrent topics in Anna Roppelt's work include Immunodeficiency and Autoimmune Disorders (12 papers), Blood disorders and treatments (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Anna Roppelt is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (12 papers), Blood disorders and treatments (4 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Anna Roppelt collaborates with scholars based in Russia, Kazakhstan and United Kingdom. Anna Roppelt's co-authors include Anna Shcherbina, Jarmila Stremenova Spegarova, Fabian Hauck, C.J. Duncan, Sally A. Cowley, G. А. Novichkova, Hugh T. Reyburn, Yulia Rodina, Elena Deripapa and William James and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Frontiers in Immunology and British Journal of Haematology.

In The Last Decade

Anna Roppelt

14 papers receiving 78 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Roppelt Russia 5 43 21 20 18 14 22 80
Jules Russick France 6 72 1.7× 19 0.9× 27 1.4× 42 2.3× 32 2.3× 10 142
Yoshiki Nakae Japan 6 18 0.4× 13 0.6× 12 0.6× 25 1.4× 25 1.8× 11 94
Tala Shahin Austria 3 76 1.8× 8 0.4× 8 0.4× 15 0.8× 12 0.9× 5 88
Erika Van Nieuwenhove Belgium 8 59 1.4× 8 0.4× 21 1.1× 15 0.8× 53 3.8× 13 132
Felix A. Radtke Germany 5 43 1.0× 8 0.4× 23 1.1× 15 0.8× 27 1.9× 6 91
Serdar Nepesov Türkiye 6 31 0.7× 8 0.4× 22 1.1× 7 0.4× 12 0.9× 19 80
Kanako Mitsui‐Sekinaka Japan 6 62 1.4× 11 0.5× 21 1.1× 8 0.4× 12 0.9× 7 82
Mofareh AlZahrani Saudi Arabia 5 37 0.9× 24 1.1× 6 0.3× 9 0.5× 11 0.8× 6 101
Tiziana Lorenzini Italy 5 73 1.7× 19 0.9× 12 0.6× 15 0.8× 20 1.4× 9 113
Thomas J Tull United Kingdom 4 62 1.4× 8 0.4× 7 0.3× 11 0.6× 25 1.8× 14 110

Countries citing papers authored by Anna Roppelt

Since Specialization
Citations

This map shows the geographic impact of Anna Roppelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Roppelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Roppelt more than expected).

Fields of papers citing papers by Anna Roppelt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Roppelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Roppelt. The network helps show where Anna Roppelt may publish in the future.

Co-authorship network of co-authors of Anna Roppelt

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Roppelt. A scholar is included among the top collaborators of Anna Roppelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Roppelt. Anna Roppelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roppelt, Anna, et al.. (2025). Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency. Frontiers in Immunology. 15. 1523256–1523256.
2.
Roppelt, Anna, et al.. (2024). New coronavirus infection SARS-CoV-2 in adult patients with inborn errors of immunity. Russian Journal of Allergy. 21(2). 216–229. 1 indexed citations
3.
4.
Roppelt, Anna, et al.. (2022). Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency. Journal of Clinical Immunology. 43(2). 440–451. 8 indexed citations
5.
Gothe, Florian, Jarmila Stremenova Spegarova, Helen Griffin, et al.. (2022). Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency. Journal of Allergy and Clinical Immunology. 150(4). 955–964.e16. 32 indexed citations
6.
Roppelt, Anna, et al.. (2022). RAPID DENSITIZATION THERAPY WITH IMIGLUCERASE IN A PATIENT WITH AN ANAPHILACTIC REACTION TO IT AGAINST THE BACKGROUND OF GAUCHER DISEASE. PEDIATRIA Journal named after G N SPERANSKY. 101(2). 121–127. 1 indexed citations
7.
Laberko, Alexandra, Anna Roppelt, Anna Mukhinа, et al.. (2022). BCG Infection in Patients With Inborn Errors of Immunity Receiving the Russian BCG Strain. The Journal of Allergy and Clinical Immunology In Practice. 10(7). 1797–1804.e7. 4 indexed citations
8.
Roppelt, Anna, et al.. (2021). Clinical case of type I interferonopathy: homozygous STAT2 gain-of-function mutation. Pediatric Hematology/Oncology and Immunopathology. 20(3). 132–139.
9.
Rodina, Yulia, Elena Deripapa, Anna Mukhinа, et al.. (2021). Rituximab and Abatacept Are Effective in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies. Frontiers in Immunology. 12. 704261–704261. 3 indexed citations
10.
Laberko, Alexandra, Elena Deripapa, Anna Roppelt, et al.. (2021). Influence of clinical and immunophenotypic variants of severe combined immunodeficiency on severity and outcomes of opportunistic infections. Pediatric Hematology/Oncology and Immunopathology. 19(4). 30–38. 3 indexed citations
11.
Laberko, Alexandra, Anna Roppelt, Elena Deripapa, et al.. (2021). Non-infectious complications in the group of pediatric patients with chronic granulomatous disease. Pediatric Hematology/Oncology and Immunopathology. 19(4). 50–61.
12.
Pershin, Dmitry, et al.. (2020). Verification of X-linked lymphoproliferative syndrome type 1 and 2 using a flow cytometry method. Pediatric Hematology/Oncology and Immunopathology. 19(4). 108–118.
13.
Pomerantseva, Ekaterina, Inna Povolotskaya, Fedor A. Konovalov, et al.. (2020). Complex Multisystem Phenotype With Immunodeficiency Associated With NBAS Mutations: Reports of Three Patients and Review of the Literature. Frontiers in Pediatrics. 8. 577–577. 7 indexed citations
14.
Deripapa, Elena, Anna Roppelt, Alexandra Laberko, et al.. (2020). CASTLEMAN DISEASE IN CHILDREN: SINGLE CENTER EXPERIENCE. PEDIATRIA Journal named after G N SPERANSKY. 99(2). 32–42. 1 indexed citations
15.
Deripapa, Elena, Yulia Rodina, Anna Roppelt, et al.. (2020). Efficacy of romiplostim in treatment of thrombocytopenia in children with Wiskott–Aldrich syndrome. British Journal of Haematology. 192(2). 366–374. 10 indexed citations
16.
Balashov, Dmitry, et al.. (2019). Х-linked lymphoproliferative syndrome. FEDERAL CLINICAL RECOMMENDATIONS, 2020. Russian Journal of Allergy. 16(4). 66–77.
17.
Deripapa, Elena, Anna Roppelt, Alexandra Laberko, et al.. (2019). Lymphoma as a rare complication of severe combined immunodeficiency. Pediatric Hematology/Oncology and Immunopathology. 18(1). 104–111.
18.
Смирнова, И. Н., et al.. (2016). Pharmacoeconomic analysis of intravenous immunoglobulin replacement therapy in patients with primary humoral immunodeficiencies. Pediatric Hematology/Oncology and Immunopathology. 15(1). 66–71.
19.
Roppelt, Anna, et al.. (2016). X-Linked lymphoproliferative syndrome types 1 and 2. Pediatric Hematology/Oncology and Immunopathology. 15(1). 17–26. 1 indexed citations
20.
Roppelt, Anna, et al.. (2015). Clinical manifestations and laboratory features of acute parvovirus infection in children with oncohematological diseases (Review of literature and clinical case reports). Pediatric Hematology/Oncology and Immunopathology. 14(4). 25–31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jules Russick Breakdown of academic impact, for papers by Yoshiki Nakae Breakdown of academic impact, for papers by Tala Shahin Breakdown of academic impact, for papers by Erika Van Nieuwenhove Breakdown of academic impact, for papers by Felix A. Radtke Breakdown of academic impact, for papers by Serdar Nepesov Breakdown of academic impact, for papers by Kanako Mitsui‐Sekinaka Breakdown of academic impact, for papers by Mofareh AlZahrani Breakdown of academic impact, for papers by Tiziana Lorenzini Breakdown of academic impact, for papers by Thomas J Tull
Rankless by CCL
2026